Preliminary evidence from two cases suggests that fecal microbiota transplantation may provide a viable treatment option for a severe adverse effect of immune checkpoint blockade therapy in patients with cancer.
- Yinghong Wang
- Diana H. Wiesnoski
- Robert R. Jenq